Cargando…
Doxorubicin-induced cardiovascular toxicity: a longitudinal evaluation of functional and molecular markers
AIMS: Apart from cardiotoxicity, the chemotherapeutic doxorubicin (DOX) induces vascular toxicity, represented by arterial stiffness and endothelial dysfunction. Both parameters are of interest for cardiovascular risk stratification as they are independent predictors of future cardiovascular events...
Autores principales: | Bosman, Matthias, Krüger, Dustin, Van Assche, Charles, Boen, Hanne, Neutel, Cédric, Favere, Kasper, Franssen, Constantijn, Martinet, Wim, Roth, Lynn, De Meyer, Guido R Y, Cillero-Pastor, Berta, Delrue, Leen, Heggermont, Ward, Van Craenenbroeck, Emeline M, Guns, Pieter-Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676457/ https://www.ncbi.nlm.nih.gov/pubmed/37625456 http://dx.doi.org/10.1093/cvr/cvad136 |
Ejemplares similares
-
Dexrazoxane does not mitigate early vascular toxicity induced by doxorubicin in mice
por: Bosman, Matthias, et al.
Publicado: (2023) -
Doxorubicin Impairs Smooth Muscle Cell Contraction: Novel Insights in Vascular Toxicity
por: Bosman, Matthias, et al.
Publicado: (2021) -
Diagnostic yield of genetic testing in heart transplant recipients with prior cardiomyopathy
por: Boen, Hanne M., et al.
Publicado: (2022) -
Toll-Like Receptors: Are They Taking a Toll on the Heart in Viral Myocarditis?
por: Favere, Kasper, et al.
Publicado: (2021) -
Addendum: B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: a case report
por: Eens, Sander, et al.
Publicado: (2023)